Advertisement Oxycodone by Indian firm receives tentative FDA approval - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Oxycodone by Indian firm receives tentative FDA approval

Indian manufacturer of drugs, Taj Pharmaceuticals has secured tentative approval from the US FDA for Abbreviated New Drug Application (ANDA), to make and sell Drug Oxycodone Tablets 5 to 30 mg in the UK and European Market.

Oxycodone is a narcotic pain-reliever and cough suppressant similar to morphine, codeine, and hydrocodone.

The drug does not eliminate the sensation of pain but provides comfort by increasing tolerance to pain, besides causing sedation and respiratory depression.

Generally, the starting dose using immediate release oxycodone tablets is 5 to 30 mg every 4 hours.